- Q3 2023 Prophase Labs Inc Earnings Call TranscriptNov 09, 2023$5.1 (+7.82%)Earnings
- Prophase Labs Inc at ThinkEquity Conference TranscriptOct 19, 2023
- Q2 2023 Prophase Labs Inc Earnings Call TranscriptAug 10, 2023$6.29 (-9.89%)Earnings
- Q1 2023 Prophase Labs Inc Earnings Call TranscriptMay 11, 2023$8.5 (-0.23%)Earnings
- Prophase Labs Inc at Precious Metals Summit Planet Microcap Showcase TranscriptApr 26, 2023
- Q4 2022 Prophase Labs Inc Earnings Call TranscriptMar 28, 2023$8.29 (+1.59%)Earnings
- Prophase Labs Inc at Issuer Direct Planet MicroCap Showcase (Virtual) TranscriptDec 07, 2022
- Prophase Labs Inc at Q4 Investor Summit TranscriptNov 14, 2022
- Q3 2022 Prophase Labs Inc Earnings Call TranscriptNov 10, 2022$11.26 (-4.90%)Earnings
- Prophase Labs Inc at ThinkEquity Conference TranscriptOct 26, 2022
- Q2 2022 Prophase Labs Inc Earnings Call TranscriptAug 11, 2022$11.5 (+7.58%)Earnings
- Q1 2022 Prophase Labs Inc Earnings Call TranscriptMay 13, 2022$7.03 (+7.82%)Earnings
- Prophase Labs Inc at Precious Metals Summit Planet Microcap Showcase TranscriptMay 04, 2022
- Prophase Labs Inc at Issuer Direct Winter Wonderland Best Ideas Investor Conference (Virtual) TranscriptFeb 09, 2022
- Q3 2021 Prophase Labs Inc Earnings Call TranscriptNov 12, 2021$5.71 (-1.38%)Earnings
- Prophase Labs Inc at SNN Network Summer Event (Virtual) TranscriptAug 18, 2021
- Q2 2021 Prophase Labs Inc Earnings Call TranscriptAug 13, 2021$6.46 (-0.46%)Earnings
- Q1 2021 Prophase Labs Inc Earnings Call TranscriptMay 13, 2021$5.56 (+3.15%)Earnings
- Q4 2020 Prophase Labs Inc Earnings Call TranscriptMar 31, 2021$7.4 (+17.94%)Earnings
Q3 2021 Prophase Labs Inc Earnings Call Transcript
Welcome to the ProPhase Labs's third-quarter 2021 financial results and corporate update conference call. (Operator Instructions)
Please note this event is being recorded. I would now like to turn the conference over to Jules Abraham with CORE IR. Please go.
Thank you, Aileen. And good morning, everyone. During this call, management will be making forward-looking statements, including statements that address ProPhase's expectations for future performance or operational results. These include statements regarding the company's expectations with respect to Q4 COVID-19 testing revenues, its goal to build a sizable customer base of independent pharmacies that will provide consistent and growing testing revenues for its diagnostics business, plans to provide genomics testing with faster turnaround times and lower price points, and ongoing efforts to evaluate and pursue additional strategic and synergistic acquisitions to build the company's precision medicine and genomics research capabilities.
Forward-looking
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)